FS Development
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch FS Development and buy or sell other stocks, ETFs, and their options commission-free!About FSDC
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
CEOJohn D. Quisel, PhD
CEOJohn D. Quisel, PhD
Employees84
Employees84
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2017
Founded2017
Employees84
Employees84
FSDC Key Statistics
Market cap47.26M
Market cap47.26M
Price-Earnings ratio-18.74
Price-Earnings ratio-18.74
Dividend yield—
Dividend yield—
Average volume371.29K
Average volume371.29K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$95.95
52 Week high$95.95
52 Week low$30.82
52 Week low$30.82
Stock Snapshot
As of today, FS Development(FSDC) shares are valued at $1.35. The company's market cap stands at 47.26M, with a P/E ratio of -18.74.
FS Development(FSDC) stock opened on 2025-11-10 at —. The price climbed to — and dipped to —.
The FS Development(FSDC)'s current trading volume is 0, compared to an average daily volume of 371.29K.
During the past year, FS Development(FSDC) stock moved between $30.82 at its lowest and $95.95 at its peak.
During the past year, FS Development(FSDC) stock moved between $30.82 at its lowest and $95.95 at its peak.
People also own
Based on the portfolios of people who own FSDC. This list is generated using Robinhood data, and it’s not a recommendation.